Sadia Ali, DPM
Podiatrist · Kennesaw, GANPI 1467614438
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by Arthrex at 30.3% of the total. Reporting peaked in 2023 at $2,279 and has fallen 85.2% since, to $338 in 2025.
Across 54 payments — averaging $63.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Treace Medical Concepts, Inc.$759
- United Orthopedics LLC$500
- Kerecis Limited$242
- Bone Support Inc.$151
- Smith+Nephew$149
- plus $581 from 16 others
What the payments were for
- Travel & lodging$1,99558%
- Food & beverage$1,42242%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 14 | $1,035 |
| Treace Medical Concepts, Inc. | 4 | $759 |
| United Orthopedics LLC | 1 | $500 |
| Kerecis Limited | 3 | $242 |
| Bone Support Inc. | 1 | $151 |
| Smith+Nephew | 7 | $149 |
| Sanara Medtech Inc. | 1 | $116 |
| Paratek Pharmaceuticals, Inc. | 4 | $73 |
| Triad Life Sciences Inc. | 2 | $73 |
| Amgen | 3 | $53 |
| Organogenesis Inc. | 2 | $42 |
| Trilliant Surgical LLC. | 1 | $35 |
| Stryker(2 entities) | 2 | $31 |
| Integra Lifesciences Corporation | 1 | $24 |
| Zimvie Inc. | 1 | $21 |
| Polynovo North America LLC | 1 | $20 |
| Celularity Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Acell, Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Polymedics Innovations Inc. | 1 | $14 |
| Nevro Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,417 in reported general payments places this provider in the 70th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 48 | $1,022 |
| Diclofenac Sodium | 24 | $551 |
| Cephalexin | 72 | $316 |
| Ketoconazole | 15 | $242 |
| Terbinafine Hcl | 13 | $210 |
| Clindamycin Hcl | 40 | $185 |
| Naproxen | 22 | $156 |
| Methylprednisolone | 29 | $155 |
| Gabapentin | 43 | $135 |
| Ciprofloxacin Hcl | 14 | $85 |
| Doxycycline Hyclate | 11 | $63 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $58 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Kennesaw
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
- Christopher CorwinJohns Creek$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.